- Home
- INLF vs APLT Comparison
INLF vs APLT Comparison
Compare INLF & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- APLT
- Stock Information
- Founded
- INLF 2016
- APLT 2016
- Country
- INLF China
- APLT United States
- Employees
- INLF N/A
- APLT N/A
- Industry
- INLF Industrial Machinery/Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- INLF Industrials
- APLT Health Care
- Exchange
- INLF Nasdaq
- APLT Nasdaq
- Market Cap
- INLF 68.4M
- APLT 80.3M
- IPO Year
- INLF 2025
- APLT 2019
- Fundamental
- Price
- INLF $2.43
- APLT $0.53
- Analyst Decision
- INLF
- APLT Buy
- Analyst Count
- INLF 0
- APLT 7
- Target Price
- INLF N/A
- APLT $6.10
- AVG Volume (30 Days)
- INLF 1.5M
- APLT 2.9M
- Earning Date
- INLF 01-01-0001
- APLT 03-05-2025
- Dividend Yield
- INLF N/A
- APLT N/A
- EPS Growth
- INLF 60.54
- APLT N/A
- EPS
- INLF 0.10
- APLT N/A
- Revenue
- INLF $14,523,935.00
- APLT N/A
- Revenue This Year
- INLF N/A
- APLT N/A
- Revenue Next Year
- INLF N/A
- APLT $2,622.90
- P/E Ratio
- INLF $28.79
- APLT N/A
- Revenue Growth
- INLF 73.92
- APLT N/A
- 52 Week Low
- INLF $2.29
- APLT $0.53
- 52 Week High
- INLF $21.00
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- INLF N/A
- APLT 29.75
- Support Level
- INLF N/A
- APLT $0.54
- Resistance Level
- INLF N/A
- APLT $0.70
- Average True Range (ATR)
- INLF 0.00
- APLT 0.06
- MACD
- INLF 0.00
- APLT 0.06
- Stochastic Oscillator
- INLF 0.00
- APLT 0.00
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd is a holding company and does business through its subsidiary. It is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.